143 related articles for article (PubMed ID: 36309400)
21. FDG-PET in the evaluation of response to nivolumab in recurrent non-small-cell lung cancer.
Higuchi M; Owada Y; Inoue T; Watanabe Y; Yamaura T; Fukuhara M; Hasegawa T; Suzuki H
World J Surg Oncol; 2016 Sep; 14(1):238. PubMed ID: 27595749
[TBL] [Abstract][Full Text] [Related]
22. Mammary analog secretory carcinoma of salivary gland with high-grade histology arising in hard palate, report of a case and review of literature.
Luo W; Lindley SW; Lindley PH; Krempl GA; Seethala RR; Fung KM
Int J Clin Exp Pathol; 2014; 7(12):9008-22. PubMed ID: 25674280
[TBL] [Abstract][Full Text] [Related]
23. [Parotid tumors of non-glandular origin: local and distant metastases in the parotid gland].
Franzen A; Pfaltz M
Laryngorhinootologie; 1997 Dec; 76(12):735-9. PubMed ID: 9487486
[TBL] [Abstract][Full Text] [Related]
24. Adenocarcinoma of minor salivary gland origin with skeletal metastasis in a child.
McDermott M; Gamis AS; el-Mofty S; Dehner LP
Pediatr Pathol Lab Med; 1996; 16(1):89-98. PubMed ID: 8963634
[TBL] [Abstract][Full Text] [Related]
25. Polymorphous low-grade adenocarcinoma of the parotid gland.
Puxeddu R; Puxeddu P; Parodo G; Faa G
Eur J Morphol; 1998 Aug; 36 Suppl():262-6. PubMed ID: 9825934
[TBL] [Abstract][Full Text] [Related]
26. The importance of postoperative radiotherapy against polymorphous low-grade adenocarcinoma of the parotid gland: case report and review of the literature.
Uemaetomari I; Tabuchi K; Tobita T; Tsuji S; Wada T; Kamma H; Hara A
Tohoku J Exp Med; 2007 Mar; 211(3):297-302. PubMed ID: 17347556
[TBL] [Abstract][Full Text] [Related]
27. Neck dissection findings in primary head and neck high-grade adenocarcinoma.
Sheahan P; Byrne M; Hafidh M; Toner M; Simon C
J Laryngol Otol; 2004 Jul; 118(7):532-6. PubMed ID: 15318960
[TBL] [Abstract][Full Text] [Related]
28. Survival after parotid gland metastases of cutaneous squamous cell carcinoma of the head and neck.
Meyer MF; Wolber P; Arolt C; Wessel M; Quaas A; Lang S; Klussmann JP; Semrau R; Beutner D
Oral Maxillofac Surg; 2021 Sep; 25(3):383-388. PubMed ID: 33400041
[TBL] [Abstract][Full Text] [Related]
29. Clinical trial of nintedanib in patients with recurrent or metastatic salivary gland cancer of the head and neck: A multicenter phase 2 study (Korean Cancer Study Group HN14-01).
Kim Y; Lee SJ; Lee JY; Lee SH; Sun JM; Park K; An HJ; Cho JY; Kang EJ; Lee HY; Kim J; Keam B; Kim HR; Lee KE; Choi MY; Lee KH; Ahn MJ
Cancer; 2017 Jun; 123(11):1958-1964. PubMed ID: 28102887
[TBL] [Abstract][Full Text] [Related]
30. Distant metastasis of parotid gland tumors.
Schwentner I; Obrist P; Thumfart W; Sprinzl G
Acta Otolaryngol; 2006 Apr; 126(4):340-5. PubMed ID: 16608783
[TBL] [Abstract][Full Text] [Related]
31. Epithelial-myoepithelial carcinoma of salivary gland with metastasis to lung: report of a case and review of the literature.
Noel S; Brozna JP
Head Neck; 1992; 14(5):401-6. PubMed ID: 1399576
[TBL] [Abstract][Full Text] [Related]
32. Carcinoma ex pleomorphic adenoma of the parotid gland.
Park KS; Kim JH; Lee DH; Lee JK; Lim SC
Am J Otolaryngol; 2022; 43(2):103389. PubMed ID: 35149345
[TBL] [Abstract][Full Text] [Related]
33. The Decline of Salivary Adenocarcinoma Not Otherwise Specified as a Tumor Entity: Reclassification Using Contemporary Immunohistochemical Profiling and Diagnostic Criteria.
Rooper LM; Mansour M; Yonescu R; Oliai BR; Bishop JA; Westra WH
Am J Surg Pathol; 2021 Jun; 45(6):753-764. PubMed ID: 33284193
[TBL] [Abstract][Full Text] [Related]
34. Parotid and neck metastases from cutaneous squamous cell carcinoma of the head and neck.
Khurana VG; Mentis DH; O'Brien CJ; Hurst TL; Stevens GN; Packham NA
Am J Surg; 1995 Nov; 170(5):446-50. PubMed ID: 7485729
[TBL] [Abstract][Full Text] [Related]
35. Metastatic tumors to the parotid and submandibular glands--analysis and differential diagnosis of 108 cases.
Seifert G; Hennings K; Caselitz J
Pathol Res Pract; 1986 Dec; 181(6):684-92. PubMed ID: 3562340
[TBL] [Abstract][Full Text] [Related]
36. Nivolumab treatment beyond RECIST-defined progression in recurrent or metastatic squamous cell carcinoma of the head and neck in CheckMate 141: A subgroup analysis of a randomized phase 3 clinical trial.
Haddad R; Concha-Benavente F; Blumenschein G; Fayette J; Guigay J; Colevas AD; Licitra L; Kasper S; Vokes EE; Worden F; Saba NF; Tahara M; Jayaprakash V; Lynch M; Li L; Gillison ML; Harrington KJ; Ferris RL
Cancer; 2019 Sep; 125(18):3208-3218. PubMed ID: 31246283
[TBL] [Abstract][Full Text] [Related]
37. Multivariate analysis of risk factors for neck metastases in surgically treated parotid carcinomas.
Régis De Brito Santos I; Kowalski LP; Cavalcante De Araujo V; Flávia Logullo A; Magrin J
Arch Otolaryngol Head Neck Surg; 2001 Jan; 127(1):56-60. PubMed ID: 11177015
[TBL] [Abstract][Full Text] [Related]
38. Nivolumab in patients with rare head and neck carcinomas: A single center's experience.
Kokkali S; Ntokou A; Drizou M; Perdikari K; Makaronis P; Katsarou E; Koufopoulos N; Tzovaras A; Ardavanis A
Oral Oncol; 2020 Feb; 101():104359. PubMed ID: 31300270
[TBL] [Abstract][Full Text] [Related]
39. Adenoid cystic carcinoma of the parotid gland associated with salivary calculi: An unusual presentation.
Shenoy VS; Kamath MP; Sreedharan S; Suhas SS
J Cancer Res Ther; 2015; 11(3):652. PubMed ID: 26458630
[TBL] [Abstract][Full Text] [Related]
40. Evaluation of salivary gland function after treatment of head-and-neck tumors with intensity-modulated radiotherapy by quantitative pertechnetate scintigraphy.
Münter MW; Karger CP; Hoffner SG; Hof H; Thilmann C; Rudat V; Nill S; Wannenmacher M; Debus J
Int J Radiat Oncol Biol Phys; 2004 Jan; 58(1):175-84. PubMed ID: 14697436
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
